Followers | 288 |
Posts | 13066 |
Boards Moderated | 0 |
Alias Born | 01/11/2018 |
Friday, January 13, 2023 9:52:41 AM
Recent WGS News
- GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients • GlobeNewswire Inc. • 06/05/2024 11:00:00 AM
- GeneDx to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/22/2024 08:05:00 PM
- GeneDx Reports First Quarter 2024 Financial Results and Business Highlights • GlobeNewswire Inc. • 04/29/2024 08:05:00 PM
- GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset • GlobeNewswire Inc. • 04/23/2024 12:30:00 PM
- GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024 • GlobeNewswire Inc. • 04/04/2024 08:05:00 PM
- GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics • GlobeNewswire Inc. • 03/14/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:33:21 PM
- GeneDx to Participate in 44th Annual Cowen Health Care Conference • GlobeNewswire Inc. • 02/26/2024 09:05:02 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/23/2024 09:56:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:28:05 PM
- GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024 • GlobeNewswire Inc. • 02/20/2024 09:26:16 PM
- GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 • GlobeNewswire Inc. • 02/01/2024 09:30:00 PM
- GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/24/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:10:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:58:39 PM
- GeneDx Announces Preliminary 2023 Financial Results • GlobeNewswire Inc. • 01/08/2024 01:55:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:03:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:25:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 02:25:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 02:24:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 09:05:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 09:04:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:45:08 PM
- GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy • GlobeNewswire Inc. • 12/01/2023 01:30:00 PM
- GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference • GlobeNewswire Inc. • 11/28/2023 09:05:00 PM
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM